Key facts
- This page summarizes Michael Ellenbogen's Form 4 filing for Evolv Technologies Holdings, Inc. (EVLV).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jan 2023, 19:24.
Michael Ellenbogen - 01 Jan 2023 Form 4 Insider Report for Evolv Technologies Holdings, Inc. (EVLV)
- Reporting relationship
- Founder & Chief Innovation Ofc, Director
- Issuer ticker
- EVLV
- Reported as of
- 01 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Jan 2023, 19:24:59 UTC
- Prior SEC filing
- 23 Sep 2022
- Next SEC filing
- 09 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Pyenson, Attorney-in-fact for Michael Ellenbogen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Ellenbogen filed Form 4 for Evolv Technologies Holdings, Inc. (EVLV) on 04 Jan 2023.
Change
- Previous filing in this sequence was filed on 23 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EVLV
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +2,500
- Change %
- +0.09%
- Price
- $0.000000
- Shares after
- 2,859,837
- Date
- 01 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EVLV
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +2,500
- Change %
- Price
- $0.000000
- Shares after
- 2,500
- Date
- 01 Jan 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 2,500
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date.